Scarica l'app Stockscreener
296.52
4.09%
-12.65
Dopo l'orario di chiusura:
296.52
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$309.17
Aprire:
$309.25
Volume 24 ore:
174.81K
Relative Volume:
0.69
Capitalizzazione di mercato:
$6.52B
Reddito:
$2.58B
Utile/perdita netta:
$-778.69M
Rapporto P/E:
-10.85
EPS:
-27.33
Flusso di cassa netto:
$223.75M
1 W Prestazione:
+5.75%
1M Prestazione:
+0.37%
6M Prestazione:
+29.26%
1 anno Prestazione:
-13.05%
Intervallo 1D:
$296.32
$311.43
Intervallo di 1 settimana:
$280.61
$311.43
Portata 52W:
$211.43
$387.99
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Nome
Bio Rad Laboratories Inc
Settore
Industria
Telefono
(510) 724-7000
Indirizzo
1000 ALFRED NOBEL DRIVE, HERCULES
Confronta BIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
296.52 | 8.37B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
133.02 | 232.77B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.90 | 143.29B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
369.24 | 140.03B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
98.33 | 126.25B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
76.72 | 44.95B | 5.69B | 1.41B | 577.90M | 6.9828 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-04-03 | Downgrade | Citigroup | Buy → Neutral |
| 2023-12-07 | Iniziato | UBS | Buy |
| 2023-06-16 | Iniziato | Wells Fargo | Overweight |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-01-28 | Reiterato | Citigroup | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2018-10-17 | Iniziato | Goldman | Buy |
| 2018-09-20 | Iniziato | Morgan Stanley | Equal-Weight |
| 2018-02-16 | Downgrade | CL King | Buy → Neutral |
| 2017-07-13 | Iniziato | Wells Fargo | Outperform |
| 2017-06-28 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2017-01-18 | Iniziato | Deutsche Bank | Hold |
| 2016-10-13 | Iniziato | CL King | Buy |
| 2015-05-06 | Reiterato | Jefferies | Buy |
| 2009-12-18 | Iniziato | Maxim Group | Buy |
| 2009-11-06 | Iniziato | Jefferies & Co | Buy |
| 2009-07-17 | Iniziato | Soleil | Buy |
| 2007-09-26 | Iniziato | Banc of America Sec | Buy |
| 2007-02-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
Mostra tutto
Bio Rad Laboratories Inc Borsa (BIO) Ultime notizie
Real-Time PCR And Digital PCR Market Size, Trends Analysis 2032 - openPR.com
United States Next Generation Sequencing Market Size, Trends & - openPR.com
A Look at Bio-Rad Laboratories’s Valuation Following Precision Medicine Push and New ddPCR Platform Launches - Sahm
Life Sciences Tools Market Size, Dynamics 2031 by Major - openPR.com
How Bio Rad Laboratories Inc. Class stock trades pre earningsJuly 2025 Decliners & Fast Gaining Stock Strategy Reports - newser.com
What institutional flow reveals about Bio Rad Laboratories Inc.Analyst Downgrade & Risk Controlled Daily Plans - newser.com
Is Bio Rad Laboratories Inc. (BUWA) stock nearing a technical breakoutJuly 2025 Levels & Expert Verified Movement Alerts - newser.com
Why Bio Rad Laboratories Inc. (BUW) stock stays resilientMarket Weekly Review & High Conviction Buy Zone Picks - newser.com
Will Bio Rad Laboratories Inc. Class stock outperform value peers2025 Year in Review & Fast Gain Stock Trading Tips - newser.com
What market sentiment indicators show for Bio Rad Laboratories Inc. (BUWA) stock2025 EndofYear Setup & Proven Capital Preservation Methods - newser.com
Why Bio Rad Laboratories Inc. Class B stock is a strong analyst pick2025 Market Outlook & Long-Term Safe Return Strategies - newser.com
Why Bio Rad Laboratories Inc. stock is favored by pension fundsWeekly Market Report & Growth Focused Stock Pick Reports - newser.com
Is Bio Rad Laboratories Inc. Class stock a top dividend aristocrat candidateBond Market & Safe Capital Growth Tips - newser.com
Why Bio Rad Laboratories Inc. Class B stock appears on watchlistsJuly 2025 PreEarnings & Verified Swing Trading Watchlists - newser.com
Can Bio Rad Laboratories Inc. (BUW) stock resist broad market declinesBond Market & Long-Term Safe Investment Plans - newser.com
Is Bio Rad Laboratories Inc. (BUWA) stock protected from inflationTrend Reversal & Verified Technical Signals - newser.com
Can Bio-Rad (BIO) Sustain Innovation Momentum After Leadership Loss and Diagnostics Expansion? - Sahm
(PDF) New insights into the sensitivity of Immulab reagent red blood cells compared to Bio-Rad, Grifols and QuidelOrtho - researchgate.net
Public Employees Retirement System of Ohio Increases Stake in Bio-Rad Laboratories, Inc. $BIO - Defense World
Liquid Chromatography Instruments Market Size & Strategic - openPR.com
Vector Purification Market Research, Industry Trends & Global Forecasts, 2035, Profiles of Agilent, BIA Separations, Bio-Rad, BioVision, Cytiva, Merck, Sartorius, Takara Bio, Thermo Fisher ScientificResearchAndMarkets.com - Business Wire
United States Multiplexed Diagnostics Market Share, Trends, - openPR.com
Will Bio Rad Laboratories Inc. (BUW) stock gain from lower interest ratesJuly 2025 News Drivers & AI Forecast Swing Trade Picks - newser.com
Nikhil Adhesives Limited Stock Analysis Technical Signals for YEARIPO Market Watch & Smart Beta Strategies That Actually Work - earlytimes.in
Chart based analysis of Bio Rad Laboratories Inc. trendsGap Up & Weekly High Conviction Ideas - newser.com
Bio-Rad extends partnership with Gencurix through strategic agreement for Droplet Digital™ PCR IVD oncology kits in Europe - News-Medical
Bio-Rad Laboratories (BIO): Is the Current Valuation Justified After Recent Share Price Uptick? - Yahoo Finance
United States Biomarker Testing Market: Precision Oncology - openPR.com
Investors in Bio-Rad Laboratories (NYSE:BIO) have unfortunately lost 47% over the last five years - Yahoo Finance
GCC Liquid Biopsy Market Forecast and Company Analysis - GlobeNewswire
GCC Liquid Biopsy Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Bio-Rad, Thermo Fisher Scientific, Johnson & Johnson, Guardant Health, QIAGEN, Sysmex - Yahoo Finance
Bio-Rad Laboratories Mourns Loss of Co-Founder Alice Schwartz - The Globe and Mail
Bio-Rad extends partnership with Gencurix through strategic agreement for Droplet Digital™ PCR IVD Oncology Kits in Europe - Cambridge Network
Bio-Rad Laboratories, Inc. Co-Founder and Director Emeritus Alice Schwartz Passes Away - MarketScreener
Future of United States HbA1c Testing Market | Diabetes - openPR.com
Exclusive Single-Cell Omics Market Report with In-Depth - openPR.com
Is Bio Rad Laboratories Inc. (BUW) stock dividend growth reliable2025 Market WrapUp & Verified Momentum Stock Watchlist - newser.com
Bio Rad Laboratories Inc Azioni (BIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.56%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):